These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4392230)

  • 61. [The action of a drug with beta-blocking action on arrhythmias caused by cardio-version].
    Parenti G; Greggia G; Sacchetti F
    Cuore Circ; 1968 Oct; 52(5):260-70. PubMed ID: 4392542
    [No Abstract]   [Full Text] [Related]  

  • 62. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
    Aellig WH; Prichard BN; Richardson GA
    Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
    [No Abstract]   [Full Text] [Related]  

  • 63. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
    [No Abstract]   [Full Text] [Related]  

  • 65. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
    Dagenais GR; Pitt B; Ross RS
    Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of oxprenolol on adrenaline-evoked ventricular arrhythmias in dogs anaesthetized with halothane in oxygen.
    Sharma PL
    Br J Anaesth; 1970 Nov; 42(11):961-6. PubMed ID: 4395141
    [No Abstract]   [Full Text] [Related]  

  • 67. Alprenolol in resuscitation.
    Pontinen J; Eggert H; Kemila S
    Br Med J; 1971 Dec; 4(5789):723. PubMed ID: 4399701
    [No Abstract]   [Full Text] [Related]  

  • 68. [Use of a beta sympatholytic agent (Trimepranol) in thyrotoxicosis].
    Blehová B; Bleha O; Hníková O; Polák E
    Cesk Pediatr; 1971 Jan; 26(1):41-3. PubMed ID: 4395985
    [No Abstract]   [Full Text] [Related]  

  • 69. Oxprenolol in Parkinson's disease.
    Jackson R; Crawford CO; Peel JS
    N Z Med J; 1971 Oct; 74(473):246-7. PubMed ID: 4399810
    [No Abstract]   [Full Text] [Related]  

  • 70. Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.
    Collins IS; King IW
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):185-94. PubMed ID: 4402011
    [No Abstract]   [Full Text] [Related]  

  • 71. Controlled trial of oxprenolol and practolol in hypertension.
    Leishman AW; Thirkettle JL; Allen BR; Dixon RA
    Br Med J; 1970 Nov; 4(5731):342-4. PubMed ID: 4394369
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Studies on the chronotropic and ionotropic effect of ICI 50.172].
    Kühn P; Niederberger M; Kummer F
    Wien Klin Wochenschr; 1971 Sep; 83(37):655-8. PubMed ID: 4398732
    [No Abstract]   [Full Text] [Related]  

  • 73. Alprenolol in the treatment of arrhythmias in acute coronary patients.
    Kreus KE; Salokannel SJ; Isomäki H; Waris EK
    Acta Med Scand; 1970 Nov; 188(5):375-8. PubMed ID: 4395252
    [No Abstract]   [Full Text] [Related]  

  • 74. [Use of practolol in arrhythmia].
    Bracchetti D; Russo F; Accorsi A
    G Clin Med; 1971 Jun; 52(6):446-74. PubMed ID: 4401175
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 76. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 77. Effects of practolol, a new adrenergic receptor blocking agent on cardiovascular responses.
    Thompson EB
    J Pharm Sci; 1972 Apr; 61(4):573-6. PubMed ID: 4401257
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
    Reynolds JL; Whitlock RM
    Br Heart J; 1972 Mar; 34(3):252-9. PubMed ID: 4111391
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of cardioselective -adrenergic blockade in patients with abnormal left ventricular function.
    Graber J; Khanna PK; Raphael MJ; Steiner RE; Webb-Peploe MM
    Br Heart J; 1971 Jul; 33(4):615. PubMed ID: 4397632
    [No Abstract]   [Full Text] [Related]  

  • 80. [Influence of a new beta receptor blockader on hemodynamics].
    Bross W; Kustrzycki A; Olejak B; Bross T; Koltowski R; Masiak M
    Med Klin; 1972 Mar; 67(11):373-81. PubMed ID: 4401684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.